| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/16/1992 | CN1064410A Process for preparing drug with carrot used as auxiliary material |
| 09/15/1992 | US5147871 Anti-bacterial cephalosporin compounds |
| 09/15/1992 | US5147861 Sanitary or surgical article |
| 09/15/1992 | US5147803 Using (di- or tri)peptides |
| 09/15/1992 | US5147651 Veterinary medicine |
| 09/15/1992 | US5147648 Method of improving the adhesiveness of gels to mucosae |
| 09/15/1992 | US5147644 Use of mixtures of polyglycerol fatty esters as emulsifiers in cosmetic and pharmaceutical formulations |
| 09/15/1992 | CA2062854A1 Pharmaceutical aerosol formulations |
| 09/15/1992 | CA1307524C Dispersions of chitin and product therefrom |
| 09/15/1992 | CA1307465C Sucralfate preparations for application on esophagus mucosa |
| 09/15/1992 | CA1307464C Lyophilized or precipitated cephalosporin zwitterion and salt composition |
| 09/15/1992 | CA1307463C Sustained release pharmaceutical compositions |
| 09/13/1992 | CA2062659A1 Composition for sustained-release of erythropoietin |
| 09/09/1992 | WO1992015331A1 Lyophilized monoclonal antibody preparation |
| 09/09/1992 | WO1992015295A1 Compositions containing sumatriptan |
| 09/09/1992 | EP0502814A2 Compositions for increasing the image contrast in imaging of the digestive tract of patients |
| 09/09/1992 | EP0502812A1 Recombinant antibodies specific for a growth factor receptor |
| 09/09/1992 | EP0502595A2 Amide chelates, their metal complexes and their use in diagnosis and therapy |
| 09/09/1992 | EP0502113A1 Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute |
| 09/09/1992 | EP0502101A1 Compositions for the treatment of hodgkin's disease |
| 09/09/1992 | EP0214281B1 Protein absorption enhancing agents |
| 09/09/1992 | CN1064218A Filler for opthalmic clinic examination |
| 09/09/1992 | CN1064217A Pneumococcal polysaccharide conjugate vaccine |
| 09/09/1992 | CA2082169A1 Freeze-dried preparation containing monoclonal antibody |
| 09/09/1992 | CA2062376A1 Medicinal composition |
| 09/08/1992 | US5146014 Inert, stable fluid |
| 09/08/1992 | US5145901 Seal, coatings, adhesiveness |
| 09/08/1992 | US5145875 Humectants for skin |
| 09/08/1992 | US5145841 Administering metal complex of xylan polysulfate |
| 09/08/1992 | US5145685 Skin treatment method and composition |
| 09/08/1992 | US5145684 Dispersion, bioavailability |
| 09/08/1992 | US5145679 Topical emollient for prevention and treatment of circulatory induced lesions |
| 09/08/1992 | CA2062454A1 Amide-chelates, their metal complexes as well as their use in diagnosis and treatment |
| 09/08/1992 | CA1307207C Steroid lotion |
| 09/03/1992 | WO1992014759A1 Carboxymethylmannoglucan and derivative thereof |
| 09/03/1992 | WO1992014758A1 Conjugate molecules |
| 09/03/1992 | WO1992014757A1 Endothelial cell-monocyte adhesion molecule |
| 09/03/1992 | WO1992014749A1 Thyroid-derived chondrocyte-stimulating factor |
| 09/03/1992 | WO1992014715A1 Sulfonyl urea derivates, method for preparing them and use thereof |
| 09/03/1992 | WO1992014543A1 Unimolecular micelles and method of making the same |
| 09/03/1992 | WO1992014491A1 Immunotoxin from anti-cd5 monoclonal antibodies |
| 09/03/1992 | WO1992014479A1 Composition for rectal administration of difficultly absorbable peptide |
| 09/03/1992 | WO1992014450A1 Sustained release drug delivery devices |
| 09/03/1992 | WO1992014449A1 Controlled release microparticulate delivery system for proteins |
| 09/03/1992 | WO1992014447A1 Binding of recognizing substances to liposomes |
| 09/03/1992 | WO1992014442A1 Composition for use in transdermal administration |
| 09/03/1992 | CA2081025A1 Carboxymethylmannoglucans and derivatives thereof |
| 09/02/1992 | EP0501763A1 Taste-masked buflomedil preparation |
| 09/02/1992 | EP0501523A1 Bioadhesive compositions |
| 09/02/1992 | EP0501267A1 Apocarotin or lycopin cyclodextrin clathrate |
| 09/02/1992 | EP0501215A2 Fusion proteins with monoclonal antibody, Linker and beta Glucuronidase for prodrug activation; preparation and use thereof |
| 09/02/1992 | EP0500893A1 Preservation of blood, tissues and biological fluids |
| 09/02/1992 | EP0500807A1 Tissue moisturizing composition and method |
| 09/02/1992 | EP0500802A1 Liposomal compositions. |
| 09/02/1992 | EP0500751A1 rRNA SPECIFIC OLIGONUCLEOTIDES |
| 09/02/1992 | EP0500658A1 A nicotine containing stimulant unit. |
| 09/02/1992 | EP0500594A1 Small particle drug compositions |
| 09/02/1992 | EP0494974A4 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems |
| 09/02/1992 | EP0335970B1 Tablet for use in the treatment of progesterone deficiency |
| 09/02/1992 | CN1064018A Processes for preparation of compositions used in treatment of cell generation disorders |
| 09/01/1992 | US5144054 Siloxane derivatives, producing method thereof and agents including siloxane derivative |
| 09/01/1992 | US5144016 Alginate gels |
| 09/01/1992 | US5144012 Cytotoxic drug conjugates |
| 09/01/1992 | US5144011 Acidity-sensitive spacer molecule to control the release of pharmaceuticals from molecular carriers |
| 09/01/1992 | US5144009 Conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, their use as immunotoxin potentiators and the intermediate activated inophores |
| 09/01/1992 | US5143940 Isopropyl myristate as fatty component |
| 09/01/1992 | US5143934 Method and composition for controlled delivery of biologically active agents |
| 09/01/1992 | US5143917 Cationic tensides for controlling infections |
| 09/01/1992 | US5143731 Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
| 09/01/1992 | US5143724 Crosslinked polysaccharides, medical use |
| 09/01/1992 | CA1306964C Method for the preparation of immunoglobulins suitable for intravenous administration |
| 09/01/1992 | CA1306949C Taste masking compositions |
| 09/01/1992 | CA1306948C Storage stable topical composition |
| 08/29/1992 | WO1992015282A2 Composition and method for delivery of drugs |
| 08/27/1992 | DE4105518A1 Sulfonylharnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung Sulfonylurea derivatives, processes for their preparation and their use |
| 08/26/1992 | EP0500143A2 Pharmaceutical composition comprising an aminoglycoside phosphate |
| 08/26/1992 | EP0499662A1 Compositions with enhanced penetration |
| 08/26/1992 | EP0499648A1 Enzymatically debranched starches as tablet excipients |
| 08/26/1992 | EP0480925A4 Fluorocarbon emulsions having saturated phospholipid emulsifiers |
| 08/26/1992 | CA2037345A1 Endothelial cell-monocyte adhesion molecule |
| 08/25/1992 | US5142047 Uncharged polynucleotide-binding polymers |
| 08/25/1992 | US5142044 Penetration enhancers for transdermal delivery of systemic agents |
| 08/25/1992 | US5142027 Cationized carriers for immunogen production |
| 08/25/1992 | US5142026 Recombinant human lymphotoxins that possess N-terminal extended linker peptides for antibody-binding sites |
| 08/25/1992 | US5141961 Mixing drug, polyethylene glycol, polyvinylpyrrolidone and solvent until dissolved, evaporating solvent |
| 08/25/1992 | US5141739 Delivery of x-ray contrast agents using receptor mediated endocytosis |
| 08/25/1992 | US5141736 Bispecific monoclonal antibody, its production and use |
| 08/25/1992 | US5141648 Methods for isolating compounds using cleavable linker bound matrices |
| 08/25/1992 | US5141575 Surface treatment for zinciferous surfaces |
| 08/25/1992 | CA1306692C Penetration enhancers for transdermal delivery of systemic agents |
| 08/25/1992 | CA1306686C Pharmaceutical composition containing ibuprofen |
| 08/25/1992 | CA1306684C Stabilisation of mercury-containing preservatives in ophthalmic medicaments |
| 08/25/1992 | CA1306677C Composition for transdermal therapeutic systems of loop diuretics and a process for its preparation |
| 08/23/1992 | WO1992014452A1 Delayed release oral dosage forms for treatment of intestinal disorders |
| 08/22/1992 | WO1992014781A1 Polyamino acid dispersants |
| 08/20/1992 | WO1992013947A1 CD4-GAMMA2 AND CD4-IgG2 CHIMERAS |
| 08/20/1992 | WO1992013915A1 Dry powder composition of hydroxyethyl starch suitable for reconstitution |
| 08/20/1992 | WO1992013875A1 Improved blood substitute |
| 08/20/1992 | WO1992013866A1 Derivatives of disaccharide alcohols, a method of preparing them, and their use |
| 08/20/1992 | WO1992013570A2 Novel complexes containing nucleic acid which can be absorbed into higher eucaryotic cells via endocytosis |